Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. These reports cover stocks to buy if you can manage the risk.
Below are our Buys for Tuesday, 22 June, as follows:
Allogene Therapeutics, Inc. (NASDAQ:ALLO): Jefferies resumed coverage with a Buy rating and a 53 price target. The stock trades in a 52-wk range of 23.30 – 46.85. The consensus price target is at 49.77.
Elastic N.V. (NYSE:ESTC): Summit Insights initiated coverage with a Buy rating and a 180 price target. The shares last closed near 144, and the consensus price target is at 171.39.
OPKO Health Inc. (NASDAQ:OPK): Ladenburg Thalmann initiated coverage with a Buy rating and a 7 price target. Shares have a consensus price target at 8.25.
Riot Blockbhain, Inc. (NASDAQ:RIOT): Compass Point initiated coverage with a Buy rating and a 43 price target. The consensus price target is at 47.94.
ResMed Inc. (NYSE:RMD): Needham reiterated a Buy rating and jumped the price target to 267 from 229. The consensus price target is at 218.40. The stock has a 52-wk range of 165.72 – 242.50 and closed Monday at 239.52/share.
Have a happy day, Keep the Faith!